Additional Options

Roxann E. Henry

Roxann Henry


Washington D.C., (202) 887-1595


Vassar College (A.B., 1975)
Rutgers, The State University of New Jersey School of Law, Camden (J.D., 1978)

Bar Admissions

New Jersey
District of Columbia


Hon. Floyd R. Gibson, U.S. Court of Appeals, Eighth Circuit (1978-1980)

Roxann Henry is a partner in the Global Antitrust Law Practice Group. With over 30 years of antitrust practice, she has extensive experience in all aspects of antitrust, including criminal defense, treble damage litigation and merger and non-merger investigations.

Ms. Henry has appeared before federal and state courts, the Federal Trade Commission (FTC), the Antitrust Division of the U.S. Department of Justice (DOJ), state attorneys general and a variety of overseas authorities, including the staff of the European Commission and Canadian Competition Bureau. Her experience spans a wide range of industries, including telecommunications, life sciences, aerospace and defense, healthcare, construction, information and social networking technologies, mining, industrial and component products, transportation services, petroleum, specialty chemicals, financial services and food and consumer products.

Ms. Henry routinely represents clients in antitrust grand jury investigations, including international cartel matters, coordinating worldwide defenses of multiple criminal, civil and administrative actions. She has represented individuals, closely held companies and large corporate industry leaders in the U.S. and abroad and, when necessary, has vindicated clients as lead counsel at trial.

Ms. Henry won a rare corporate not-guilty jury verdict in a criminal antitrust trial and won the first court victory in over a decade against an FTC non-healthcare merger challenge. She has served as lead counsel in various complex civil commercial disputes, including antitrust, RICO, contract and tort claims, and provides antitrust and trade practices counseling and merger antitrust clearances.

Ms. Henry currently serves as Chair of the Antitrust Section of the American Bar Association (ABA) and has previously served as International Officer, Program Officer, co-chair of the Spring Meeting, and council member. At the invitation of the Department of Justice and Federal Trade Commission, Ms. Henry serves as a Non-Governmental Advisor to the International Competition Network (ICN), an organization of more than 100 competition agencies from around the world that works to address antitrust enforcement and policy issues. She is a frequent speaker on antitrust issues.

Ms. Henry received her A.B. from Vassar College in 1975, and her J.D. cum laude from Rutgers University School of Law in 1978 where she was the articles editor of the Rutgers Law Journal. She completed a Leadership Course from Harvard Business School in 2007. She is admitted as an attorney in District of Columbia, New Jersey and Pennsylvania.

Representative Matters Include:

  • Arch Coal’s Acquisition of Triton
    With the first court win in over a decade against an FTC merger challenge in a non-healthcare case, gained clearance for Arch Coal to buy the North Rochelle mine and create the largest U.S. coal mine.
  • Criminal Antitrust/Trial Victory
    Secured one of the rare corporate not-guilty verdicts after a full criminal antitrust trial.

    Represented clients in well over 50 antitrust grand jury proceedings spanning every current and former office of the DoJ Antitrust Division. Representation in criminal matters has encompassed a wide array of industries and included Fortune 100 and closely held corporations, domestic and international, as well as individuals.
  • Arbitron Sale to Nielsen
    Secured clearance with creative fix to overcome FTC challenge to overlap in potential market.
  • Nestlé Acquisitions
    Representative acquisitions include obtaining FTC clearance for Nestlé in its $40 billion sale of Alcon stock to Novartis and its acquisitions of Gerber ($5.5 billion) and Novartis Medical Nutrition Business ($2.5 billion), of Dreyer’s Ice Cream ($2.8 billion), and of Ralston Purina ($11 billion).